Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbro Linderholm

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
European Journal of Clinical Pharmacology|June 7, 2020
Personalised medicine and the decision to withhold chemotherapy in early breast cancer with intermediate risk of recurrence - a systematic review and meta-analysisSusanna M Wallerstedt, Astrid Nilsson Ek, Roger Olofsson Bagge, et al.
European Journal of Cancer (Oxford, England : 1990)|November 3, 2004
Thrombospondin-1 expression in relation to p53 status and VEGF expression in human breast cancersBarbro Linderholm, Eva Karlsson, Sigrid Klaar, et al.
Pharmacoeconomics - Open|December 13, 2023
Cost-Effectiveness Analysis of Adjuvant Olaparib Versus Watch and Wait in the Treatment of Germline BRCA1/2-Mutated, High-Risk, HER2-Negative Early Breast Cancer in SwedenMaria Polyzoi, Mattias Ekman, Anja Reithmeier, et al.
Plos One|March 14, 2020
Communicative challenges among physicians, patients, and family caregivers in cancer care: An exploratory qualitative study in EthiopiaBethlehem Girma Kebede, Aynalem Abraha, Rune Andersson, et al.
JMIR Research Protocols|May 20, 2020
Person and Family Centeredness in Ethiopian Cancer Care: Proposal for a Project for Improving Communication, Ethics, Decision Making, and HealthNataliya Berbyuk Lindström, Aynalem Abraha Woldemariam, Abebe Bekele, et al.
European Journal of Cancer (Oxford, England : 1990)|September 9, 2010
Diagnostic and prognostic role of plasma levels of two forms of cytokeratin 18 in patients with non-small-cell lung cancerLuigi De Petris, Eva Brandén, Richard Herrmann, et al.
Breast (Edinburgh, Scotland)|March 8, 2020
Clinical outcome of patients with brain metastases from breast cancer - A population based study over 21 yearsAnna Thulin, Elisabeth Rönnerman, Chenyang Zhang, et al.
European Journal of Cancer (Oxford, England : 1990)|April 11, 2006
Activated ERK1/2 and phosphorylated oestrogen receptor alpha are associated with improved breast cancer survival in women treated with tamoxifenJenny Bergqvist, Goran Elmberger, John Ohd, et al.
The Lancet. Healthy Longevity|September 12, 2022
Adjuvant chemotherapy and survival in women aged 70 years and older with triple-negative breast cancer: a Swedish population-based propensity score-matched analysisSlavica Janeva, Chenyang Zhang, Anikó Kovács, et al.
Acta Oncologica (Stockholm, Sweden)|August 28, 2002
A population-based study on the first forty-eight breast cancer patients receiving trastuzumab (Herceptin) on a named patient basis in SwedenJenny Andersson, Barbro Linderholm, Gudrun Greim, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
European Journal of Clinical Pharmacology|June 7, 2020
Personalised medicine and the decision to withhold chemotherapy in early breast cancer with intermediate risk of recurrence - a systematic review and meta-analysisSusanna M Wallerstedt, Astrid Nilsson Ek, Roger Olofsson Bagge, et al.
European Journal of Cancer (Oxford, England : 1990)|November 3, 2004
Thrombospondin-1 expression in relation to p53 status and VEGF expression in human breast cancersBarbro Linderholm, Eva Karlsson, Sigrid Klaar, et al.
Pharmacoeconomics - Open|December 13, 2023
Cost-Effectiveness Analysis of Adjuvant Olaparib Versus Watch and Wait in the Treatment of Germline BRCA1/2-Mutated, High-Risk, HER2-Negative Early Breast Cancer in SwedenMaria Polyzoi, Mattias Ekman, Anja Reithmeier, et al.
Plos One|March 14, 2020
Communicative challenges among physicians, patients, and family caregivers in cancer care: An exploratory qualitative study in EthiopiaBethlehem Girma Kebede, Aynalem Abraha, Rune Andersson, et al.
JMIR Research Protocols|May 20, 2020
Person and Family Centeredness in Ethiopian Cancer Care: Proposal for a Project for Improving Communication, Ethics, Decision Making, and HealthNataliya Berbyuk Lindström, Aynalem Abraha Woldemariam, Abebe Bekele, et al.
European Journal of Cancer (Oxford, England : 1990)|September 9, 2010
Diagnostic and prognostic role of plasma levels of two forms of cytokeratin 18 in patients with non-small-cell lung cancerLuigi De Petris, Eva Brandén, Richard Herrmann, et al.
Breast (Edinburgh, Scotland)|March 8, 2020
Clinical outcome of patients with brain metastases from breast cancer - A population based study over 21 yearsAnna Thulin, Elisabeth Rönnerman, Chenyang Zhang, et al.
European Journal of Cancer (Oxford, England : 1990)|April 11, 2006
Activated ERK1/2 and phosphorylated oestrogen receptor alpha are associated with improved breast cancer survival in women treated with tamoxifenJenny Bergqvist, Goran Elmberger, John Ohd, et al.
The Lancet. Healthy Longevity|September 12, 2022
Adjuvant chemotherapy and survival in women aged 70 years and older with triple-negative breast cancer: a Swedish population-based propensity score-matched analysisSlavica Janeva, Chenyang Zhang, Anikó Kovács, et al.
Acta Oncologica (Stockholm, Sweden)|August 28, 2002
A population-based study on the first forty-eight breast cancer patients receiving trastuzumab (Herceptin) on a named patient basis in SwedenJenny Andersson, Barbro Linderholm, Gudrun Greim, et al.
Pageof 5